Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	689.89	517.55	137.64	298.4	171.45	130.24
Short-Term Investments	-	-	-	-	19.82	10.04
Cash & Short-Term Investments	689.89	517.55	137.64	298.4	191.27	140.28
Cash Growth	55.97%	276.03%	-53.87%	56.01%	36.35%	48.41%
Accounts Receivable	106.44	65.49	53.65	10.79	6.72	6.42
Other Receivables	0.36	-	-	-	-	-
Receivables	106.8	65.49	53.65	10.79	6.72	6.42
Inventory	28.03	19.54	15.64	6.81	7.87	4.65
Prepaid Expenses	24.23	20	12.05	4.32	3.92	7.45
Other Current Assets	3.5	1.03	0.35	0.49	0.33	0.45
Total Current Assets	852.45	623.61	219.33	320.81	210.11	159.24
Property, Plant & Equipment	3.09	3.58	3.7	3.62	3.98	0.13
Long-Term Investments	19.17	21.56	16.49	-	-	-
Other Intangible Assets	128.64	156.67	194.05	32.47	-	-
Long-Term Deferred Tax Assets	48.26	45.98	36.54	18.74	23.7	32.97
Other Long-Term Assets	-	-	-	-	0.01	0.01
Total Assets	1,052	851.41	470.11	375.63	237.79	192.35
Accounts Payable	9.1	16.59	14.8	3.98	2.77	4.26
Accrued Expenses	53.52	53.85	40.29	27.83	21.95	17.4
Current Portion of Leases	0.43	0.4	0.37	0.34	0.31	0.03
Current Income Taxes Payable	0.71	0.89	0.73	8.7	0.08	-
Other Current Liabilities	64.98	48.94	19.88	16.75	1.96	1.07
Total Current Liabilities	128.74	120.68	76.06	57.59	27.06	22.76
Long-Term Leases	2.46	2.79	3.19	3.56	3.89	-
Other Long-Term Liabilities	0.16	0.32	2.98	14.06	-	-
Total Liabilities	131.36	123.78	82.23	75.21	30.96	22.76
Common Stock	0.12	0.12	0.11	0.11	0.1	0.1
Additional Paid-In Capital	473.33	442.29	266.49	250.43	233.19	223.17
Retained Earnings	446.79	285.16	121.27	49.86	-26.31	-53.71
Comprehensive Income & Other	-	0.06	0.01	0.02	-0.15	0.03
Shareholders' Equity	920.25	727.63	387.88	300.42	206.83	169.6
Total Liabilities & Equity	1,052	851.41	470.11	375.63	237.79	192.35
Total Debt	2.89	3.19	3.56	3.89	4.2	0.03
Net Cash (Debt)	687	514.37	134.08	294.5	187.06	140.25
Net Cash Growth	56.47%	283.63%	-54.47%	57.43%	33.38%	49.89%
Net Cash Per Share	5.41	4.12	1.18	2.64	1.74	1.32
Filing Date Shares Outstanding	122.91	121.45	117.86	105.65	102.74	103.82
Total Common Shares Outstanding	123.26	120.88	107.12	105.26	102.99	103.78
Working Capital	723.72	502.93	143.27	263.22	183.04	136.49
Book Value Per Share	7.47	6.02	3.62	2.85	2.01	1.63
Tangible Book Value	791.61	570.96	193.83	267.95	206.83	169.6
Tangible Book Value Per Share	6.42	4.72	1.81	2.55	2.01	1.63
Machinery	1.08	1.05	0.49	0.27	0.25	0.29
Leasehold Improvements	0.99	0.99	0.99	0.98	0.98	0.18

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q